Cyclodextrins in Pharmaceutical - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510246891

Publication Date:

October 11, 2024

Pages:

129

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Cyclodextrins are听cyclic oligomers of glucose听that have a significant number of applications in the pharmaceutical industries. Water-soluble cyclodextrins can form inclusion complexes with small molecules and portions of large compounds that have limited aqueous solubility to provide improved bioavailability of drugs.
The global market for Cyclodextrins in Pharmaceutical was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cyclodextrins in Pharmaceutical, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cyclodextrins in Pharmaceutical by region & country, by Type, and by Application.
The Cyclodextrins in Pharmaceutical market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclodextrins in Pharmaceutical.
麻豆原创 Segmentation
By Company
Ashland
Cambrex Corporation
Cayman Chemical
Cyclo Therapeutics
Ligand Pharmaceuticals Incorporated
Merck KGaA
Midas Pharma GmbH
Otto Chemie
TCI Chemicals
VIO CHEMICALS
Wacker Chemie AG
Wellona Pharma
Segment by Type:
Solid
Liquid
Segment by Application
Drug Safety
Medical Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cyclodextrins in Pharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cyclodextrins in Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cyclodextrins in Pharmaceutical in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Cyclodextrins in Pharmaceutical Product Introduction
1.2 Global Cyclodextrins in Pharmaceutical 麻豆原创 Size Forecast
1.2.1 Global Cyclodextrins in Pharmaceutical Sales Value (2019-2030)
1.2.2 Global Cyclodextrins in Pharmaceutical Sales Volume (2019-2030)
1.2.3 Global Cyclodextrins in Pharmaceutical Sales Price (2019-2030)
1.3 Cyclodextrins in Pharmaceutical 麻豆原创 Trends & Drivers
1.3.1 Cyclodextrins in Pharmaceutical Industry Trends
1.3.2 Cyclodextrins in Pharmaceutical 麻豆原创 Drivers & Opportunity
1.3.3 Cyclodextrins in Pharmaceutical 麻豆原创 Challenges
1.3.4 Cyclodextrins in Pharmaceutical 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cyclodextrins in Pharmaceutical Players Revenue Ranking (2023)
2.2 Global Cyclodextrins in Pharmaceutical Revenue by Company (2019-2024)
2.3 Global Cyclodextrins in Pharmaceutical Players Sales Volume Ranking (2023)
2.4 Global Cyclodextrins in Pharmaceutical Sales Volume by Company Players (2019-2024)
2.5 Global Cyclodextrins in Pharmaceutical Average Price by Company (2019-2024)
2.6 Key Manufacturers Cyclodextrins in Pharmaceutical Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Cyclodextrins in Pharmaceutical Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Cyclodextrins in Pharmaceutical
2.9 Cyclodextrins in Pharmaceutical 麻豆原创 Competitive Analysis
2.9.1 Cyclodextrins in Pharmaceutical 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Cyclodextrins in Pharmaceutical Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclodextrins in Pharmaceutical as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Solid
3.1.2 Liquid
3.2 Global Cyclodextrins in Pharmaceutical Sales Value by Type
3.2.1 Global Cyclodextrins in Pharmaceutical Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cyclodextrins in Pharmaceutical Sales Value, by Type (2019-2030)
3.2.3 Global Cyclodextrins in Pharmaceutical Sales Value, by Type (%) (2019-2030)
3.3 Global Cyclodextrins in Pharmaceutical Sales Volume by Type
3.3.1 Global Cyclodextrins in Pharmaceutical Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Cyclodextrins in Pharmaceutical Sales Volume, by Type (2019-2030)
3.3.3 Global Cyclodextrins in Pharmaceutical Sales Volume, by Type (%) (2019-2030)
3.4 Global Cyclodextrins in Pharmaceutical Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Drug Safety
4.1.2 Medical Laboratory
4.1.3 Others
4.2 Global Cyclodextrins in Pharmaceutical Sales Value by Application
4.2.1 Global Cyclodextrins in Pharmaceutical Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cyclodextrins in Pharmaceutical Sales Value, by Application (2019-2030)
4.2.3 Global Cyclodextrins in Pharmaceutical Sales Value, by Application (%) (2019-2030)
4.3 Global Cyclodextrins in Pharmaceutical Sales Volume by Application
4.3.1 Global Cyclodextrins in Pharmaceutical Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Cyclodextrins in Pharmaceutical Sales Volume, by Application (2019-2030)
4.3.3 Global Cyclodextrins in Pharmaceutical Sales Volume, by Application (%) (2019-2030)
4.4 Global Cyclodextrins in Pharmaceutical Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Cyclodextrins in Pharmaceutical Sales Value by Region
5.1.1 Global Cyclodextrins in Pharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cyclodextrins in Pharmaceutical Sales Value by Region (2019-2024)
5.1.3 Global Cyclodextrins in Pharmaceutical Sales Value by Region (2025-2030)
5.1.4 Global Cyclodextrins in Pharmaceutical Sales Value by Region (%), (2019-2030)
5.2 Global Cyclodextrins in Pharmaceutical Sales Volume by Region
5.2.1 Global Cyclodextrins in Pharmaceutical Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Cyclodextrins in Pharmaceutical Sales Volume by Region (2019-2024)
5.2.3 Global Cyclodextrins in Pharmaceutical Sales Volume by Region (2025-2030)
5.2.4 Global Cyclodextrins in Pharmaceutical Sales Volume by Region (%), (2019-2030)
5.3 Global Cyclodextrins in Pharmaceutical Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Cyclodextrins in Pharmaceutical Sales Value, 2019-2030
5.4.2 North America Cyclodextrins in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Cyclodextrins in Pharmaceutical Sales Value, 2019-2030
5.5.2 Europe Cyclodextrins in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Cyclodextrins in Pharmaceutical Sales Value, 2019-2030
5.6.2 Asia Pacific Cyclodextrins in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Cyclodextrins in Pharmaceutical Sales Value, 2019-2030
5.7.2 South America Cyclodextrins in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Cyclodextrins in Pharmaceutical Sales Value, 2019-2030
5.8.2 Middle East & Africa Cyclodextrins in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cyclodextrins in Pharmaceutical Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cyclodextrins in Pharmaceutical Sales Value
6.2.1 Key Countries/Regions Cyclodextrins in Pharmaceutical Sales Value, 2019-2030
6.2.2 Key Countries/Regions Cyclodextrins in Pharmaceutical Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Cyclodextrins in Pharmaceutical Sales Value, 2019-2030
6.3.2 United States Cyclodextrins in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cyclodextrins in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cyclodextrins in Pharmaceutical Sales Value, 2019-2030
6.4.2 Europe Cyclodextrins in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cyclodextrins in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cyclodextrins in Pharmaceutical Sales Value, 2019-2030
6.5.2 China Cyclodextrins in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cyclodextrins in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cyclodextrins in Pharmaceutical Sales Value, 2019-2030
6.6.2 Japan Cyclodextrins in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cyclodextrins in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cyclodextrins in Pharmaceutical Sales Value, 2019-2030
6.7.2 South Korea Cyclodextrins in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cyclodextrins in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cyclodextrins in Pharmaceutical Sales Value, 2019-2030
6.8.2 Southeast Asia Cyclodextrins in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cyclodextrins in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cyclodextrins in Pharmaceutical Sales Value, 2019-2030
6.9.2 India Cyclodextrins in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cyclodextrins in Pharmaceutical Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Ashland
7.1.1 Ashland Company Information
7.1.2 Ashland Introduction and Business Overview
7.1.3 Ashland Cyclodextrins in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Ashland Cyclodextrins in Pharmaceutical Product Offerings
7.1.5 Ashland Recent Development
7.2 Cambrex Corporation
7.2.1 Cambrex Corporation Company Information
7.2.2 Cambrex Corporation Introduction and Business Overview
7.2.3 Cambrex Corporation Cyclodextrins in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Cambrex Corporation Cyclodextrins in Pharmaceutical Product Offerings
7.2.5 Cambrex Corporation Recent Development
7.3 Cayman Chemical
7.3.1 Cayman Chemical Company Information
7.3.2 Cayman Chemical Introduction and Business Overview
7.3.3 Cayman Chemical Cyclodextrins in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Cayman Chemical Cyclodextrins in Pharmaceutical Product Offerings
7.3.5 Cayman Chemical Recent Development
7.4 Cyclo Therapeutics
7.4.1 Cyclo Therapeutics Company Information
7.4.2 Cyclo Therapeutics Introduction and Business Overview
7.4.3 Cyclo Therapeutics Cyclodextrins in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Cyclo Therapeutics Cyclodextrins in Pharmaceutical Product Offerings
7.4.5 Cyclo Therapeutics Recent Development
7.5 Ligand Pharmaceuticals Incorporated
7.5.1 Ligand Pharmaceuticals Incorporated Company Information
7.5.2 Ligand Pharmaceuticals Incorporated Introduction and Business Overview
7.5.3 Ligand Pharmaceuticals Incorporated Cyclodextrins in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Ligand Pharmaceuticals Incorporated Cyclodextrins in Pharmaceutical Product Offerings
7.5.5 Ligand Pharmaceuticals Incorporated Recent Development
7.6 Merck KGaA
7.6.1 Merck KGaA Company Information
7.6.2 Merck KGaA Introduction and Business Overview
7.6.3 Merck KGaA Cyclodextrins in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Merck KGaA Cyclodextrins in Pharmaceutical Product Offerings
7.6.5 Merck KGaA Recent Development
7.7 Midas Pharma GmbH
7.7.1 Midas Pharma GmbH Company Information
7.7.2 Midas Pharma GmbH Introduction and Business Overview
7.7.3 Midas Pharma GmbH Cyclodextrins in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Midas Pharma GmbH Cyclodextrins in Pharmaceutical Product Offerings
7.7.5 Midas Pharma GmbH Recent Development
7.8 Otto Chemie
7.8.1 Otto Chemie Company Information
7.8.2 Otto Chemie Introduction and Business Overview
7.8.3 Otto Chemie Cyclodextrins in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Otto Chemie Cyclodextrins in Pharmaceutical Product Offerings
7.8.5 Otto Chemie Recent Development
7.9 TCI Chemicals
7.9.1 TCI Chemicals Company Information
7.9.2 TCI Chemicals Introduction and Business Overview
7.9.3 TCI Chemicals Cyclodextrins in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.9.4 TCI Chemicals Cyclodextrins in Pharmaceutical Product Offerings
7.9.5 TCI Chemicals Recent Development
7.10 VIO CHEMICALS
7.10.1 VIO CHEMICALS Company Information
7.10.2 VIO CHEMICALS Introduction and Business Overview
7.10.3 VIO CHEMICALS Cyclodextrins in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.10.4 VIO CHEMICALS Cyclodextrins in Pharmaceutical Product Offerings
7.10.5 VIO CHEMICALS Recent Development
7.11 Wacker Chemie AG
7.11.1 Wacker Chemie AG Company Information
7.11.2 Wacker Chemie AG Introduction and Business Overview
7.11.3 Wacker Chemie AG Cyclodextrins in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Wacker Chemie AG Cyclodextrins in Pharmaceutical Product Offerings
7.11.5 Wacker Chemie AG Recent Development
7.12 Wellona Pharma
7.12.1 Wellona Pharma Company Information
7.12.2 Wellona Pharma Introduction and Business Overview
7.12.3 Wellona Pharma Cyclodextrins in Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Wellona Pharma Cyclodextrins in Pharmaceutical Product Offerings
7.12.5 Wellona Pharma Recent Development
8 Industry Chain Analysis
8.1 Cyclodextrins in Pharmaceutical Industrial Chain
8.2 Cyclodextrins in Pharmaceutical Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cyclodextrins in Pharmaceutical Sales Model
8.5.2 Sales Channel
8.5.3 Cyclodextrins in Pharmaceutical Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Ashland
Cambrex Corporation
Cayman Chemical
Cyclo Therapeutics
Ligand Pharmaceuticals Incorporated
Merck KGaA
Midas Pharma GmbH
Otto Chemie
TCI Chemicals
VIO CHEMICALS
Wacker Chemie AG
Wellona Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.